Terms: = Kidney tumors AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Prognosis
6 results:
1. Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.
Azuma T; Sato Y; Ohno T; Azuma M; Kume H
PLoS One; 2018; 13(7):e0199719. PubMed ID: 30044793
[TBL] [Abstract] [Full Text] [Related]
2. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract] [Full Text] [Related]
3. Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.
Quandt D; Jasinski-Bergner S; Müller U; Schulze B; Seliger B
J Transl Med; 2014 May; 12():151. PubMed ID: 24885059
[TBL] [Abstract] [Full Text] [Related]
4. Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma.
Ohno Y; Nakashima J; Nakagami Y; Satake N; Gondo T; Ohori M; Hatano T; Tachibana M
Br J Cancer; 2013 Oct; 109(7):1899-903. PubMed ID: 24002606
[TBL] [Abstract] [Full Text] [Related]
5. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma.
Mosashvilli D; Kahl P; Mertens C; Holzapfel S; Rogenhofer S; Hauser S; Büttner R; Von Ruecker A; Müller SC; Ellinger J
Cancer Sci; 2010 Dec; 101(12):2664-9. PubMed ID: 20825416
[TBL] [Abstract] [Full Text] [Related]
6. Risk stratification and prognostication of renal cell carcinoma.
Ficarra V; Galfano A; Novara G; Iafrate M; Brunelli M; Secco S; Cavalleri S; Martignoni G; Artibani W
World J Urol; 2008 Apr; 26(2):115-25. PubMed ID: 18392834
[TBL] [Abstract] [Full Text] [Related]
